David Yi

David Yi

ID: 1b839951-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Pharma in Brief: The 2021 Year in Review

Pharma in Brief · January 9, 2022

ONSC dismisses Apotex’s second monopolies action

Pharma in Brief · October 6, 2021

Amendments to the Federal Courts Rules

Pharma in Brief · July 7, 2021

Proposed amendments to the PM(NOC) Regulations: Patents claiming different salt forms of medicinal ingredients eligible for inclusion on the Patent Register

Pharma in Brief · April 25, 2021

Ontario Superior Court summarily dismisses Apotex’s novel monetary claims under Statutes of Monopolies, Trademarks Act, and at common law

Pharma in Brief · March 18, 2021

Practice Areas

Health Care and Life Sciences

Jurisdictions